International Journal of
Reproductive Biomedicine
Mon, Dec 8, 2025
[Archive]
Volume 23, Issue 10 (October 2025)
IJRM 2025, 23(10): 803-814 |
Back to browse issues page
Ethics code: IR.SBMU.RETECH.REC.1401.071
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Majidipour N, Sabbagh S, Nazarian H, Pourmotahari F, Azizolahi B. Evaluation of acute and chronic phases of COVID-19 on semen parameters and gonad hormones: A case-control study. IJRM 2025; 23 (10) :803-814
URL: http://ijrm.ir/article-1-3609-en.html
URL: http://ijrm.ir/article-1-3609-en.html
1- Department of Nursing, School of Nursing, Dezful University of Medical Sciences, Dezful, Iran.
2- Department of Anatomical Sciences, Faculty of Medicine, Dezful University of Medical Sciences, Dezful, Iran.
3- Men’s Health and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
4- Department of Public Health and Community Medicine, School of Medicine, Dezful University of Medical Sciences, Dezful, Iran.
5- Department of Laboratory Sciences, School of Paramedicine, Dezful University of Medical Sciences, Dezful, Iran. & Infectious and Tropical Diseases Research Center, Dezful University of Medical Sciences, Dezful, Iran. ,behnam.azizolahi@yahoo.com; azizolahi.b@dums.ac.ir
2- Department of Anatomical Sciences, Faculty of Medicine, Dezful University of Medical Sciences, Dezful, Iran.
3- Men’s Health and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
4- Department of Public Health and Community Medicine, School of Medicine, Dezful University of Medical Sciences, Dezful, Iran.
5- Department of Laboratory Sciences, School of Paramedicine, Dezful University of Medical Sciences, Dezful, Iran. & Infectious and Tropical Diseases Research Center, Dezful University of Medical Sciences, Dezful, Iran. ,
Abstract: (69 Views)
Background: Since the outbreak of coronavirus disease 2019 (COVID-19), many studies have provided evidence supporting the adverse effects of this condition on the male reproductive system.
Objective: This study aimed to investigate the acute and chronic effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, the Omicron variant, on different aspects of male reproductive function.
Materials and Methods: This case-control study was performed at Ganjavian hospital in Dezful, Iran from July 2022-January 2023. Participants were stratified into COVID+ (n = 35) and COVID- (n = 35) groups. The study evaluated semen parameters, SARS-CoV-2 ribonucleic acid, oxidative stress (OS) markers, and sex hormones.
Results: The study revealed significant differences in semen parameters consisting of motility (p < 0.001), progressive motility (p < 0.001), and normal morphology (p = 0.001) between the study groups, as well as within the COVID+ group comparing the acute and chronic phases. Sperm motility was significantly impaired during the acute phase of COVID-19 but showed improvement in the chronic phase (p < 0.001), indicating the effect may be temporary. Significant differences were also observed in follicle-stimulating hormone, luteinizing hormone, and OS markers (p < 0.001) between the COVID+ and COVID- groups. However, SARS-CoV-2 ribonucleic acid was not detected in any of the semen samples.
Conclusion: In vaccinated men, acute SARS-CoV-2 Omicron infection impaired semen quality elevated OS, and reduced testosterone. These effects are likely caused by fever and testicular inflammation, which can lead to secondary hypogonadism. Moreover, vaccination could likely improve semen quality, but has no protection against secondary hypogonadism.
Objective: This study aimed to investigate the acute and chronic effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, the Omicron variant, on different aspects of male reproductive function.
Materials and Methods: This case-control study was performed at Ganjavian hospital in Dezful, Iran from July 2022-January 2023. Participants were stratified into COVID+ (n = 35) and COVID- (n = 35) groups. The study evaluated semen parameters, SARS-CoV-2 ribonucleic acid, oxidative stress (OS) markers, and sex hormones.
Results: The study revealed significant differences in semen parameters consisting of motility (p < 0.001), progressive motility (p < 0.001), and normal morphology (p = 0.001) between the study groups, as well as within the COVID+ group comparing the acute and chronic phases. Sperm motility was significantly impaired during the acute phase of COVID-19 but showed improvement in the chronic phase (p < 0.001), indicating the effect may be temporary. Significant differences were also observed in follicle-stimulating hormone, luteinizing hormone, and OS markers (p < 0.001) between the COVID+ and COVID- groups. However, SARS-CoV-2 ribonucleic acid was not detected in any of the semen samples.
Conclusion: In vaccinated men, acute SARS-CoV-2 Omicron infection impaired semen quality elevated OS, and reduced testosterone. These effects are likely caused by fever and testicular inflammation, which can lead to secondary hypogonadism. Moreover, vaccination could likely improve semen quality, but has no protection against secondary hypogonadism.
Type of Study: Original Article |
Subject:
Reproductive Andrology
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
